Ataluren Update- Phase 3 trial planned for 2014
PTC had their first investor conference yesterday, here is a brief summary:
- Second phase 3 Ataluren study planned to start in the first half of 2014 with CF nonsense mutations
- Plan to apply to the EMA (Europe) this year
- Potential for combination with Vertex's Kalydeco discussed during investor conference, PTC looking at ways to evaluate this concept
More info here: http://sixtyfiverosesblog.wordpress....aluren-update/
Source: Cystic Fibrosis CFTR Modulation and Gene Therapy Forum - Category: Respiratory Medicine Authors: GenH Tags: CFTR Modulation and Gene Therapy Talk Source Type: forums